Business Wire

SYNAPS Dx DISCERN™ Test Provides Accurate Diagnosis of Alzheimer’s Disease, Optimizes Prescribing, Minimizes Patient Risks and Informs Coverage Decisions for Leqembi™

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx) a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes the ...
Yahoo Finance

DISCERN Insights-as-a-Service Platform Now Optimizes Retail Investment Decisions

SAN MATEO, CA--(Marketwired - May 11, 2016) - DISCERN, the leader in Insights-as-a-Service for investment professionals and corporate executives, today announced DISCERN Retail Data-as-a-Service for ...
Business Wire

SYNAPS Dx Releases Autopsy-Confirmed Results for DISCERN™ Alzheimer’s Test and Physicians’ Assessment of Clinical Utility of DISCERN at BRAINWeek 2023

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recently ...
pharmaphorum

W2O acquires health policy consulting firm Discern Health

W2O has bought US health economics and outcomes research company Discern Health, marking its sixth acquisition in less than a year. The move will give Discern Health access to healthcare ...
Medindia

Value-based Purchasing Authority Dr. Thomas Valuck Joins Discern

Thomas Valuck, MD, JD, has joined Discern as a Partner to help clients drive health system improvement and navigate post-reform challenges. Dr. Valuck is a nationally respected expert in value-based ...